📌 Key Takeaways
- Topic: What Is E551? Silicon Dioxide as a Food Additive, Uses and Safety
- Keywords: quartz
- Published: 2026-11-20 00:28:27
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Nevertheless, mesoporous carriers are frequently associated with poor tabletability because of bad powder flow behavior; thus, direct tableting can only be attained by adding diverse excipients in large quantities [ 95 ]. Such useful excipients include microcrystalline cellulose (filler), lactose monohydrate (filler), PVP (binder), sodium carboxymethylcellulose (disintegrant), croscarmellose sodium (super disintegrant), colloidal silica (anti-adhesion material), magnesium stearate (lubricant), and talc (lubricant) [ 39, 95, 96, 97 ]. However, the drug content in the dosage unit decreases with high amounts of excipients added, so larger tablets must be designed to attain the proper dose [ 95 ]. Another issue is that the greater compression force used during tableting may deform and damage the pore structure of the carrier, which might decrease the expected drug release rate [ 36, 97, 98 ]. When higher compression forces are applied, the pore diameter decreases, which affects both total pore volume and particular surface region, reducing the drug release rate from the carrier [ 97, 98 ]. The use of microcrystalline cellulose may be a solution to this problem, as it deforms plastically under pressure while distributing the energy accumulated in the tablet during compression. Furthermore, croscarmellose sodium may improve the drug release rate [ 97, 98 ]. Granulation of mesoporous material is a proper choice to solve issues related to poor powder rheology.
Monocrystalline Silicon vs Silica: How Silicon Wafers Are Made from Quartz
- 325 Mesh Silica: Particle Size, Specifications and Common Applications
- Magnetic particles were synthesized with an iron-containing coating. The model drugs were safranin O and hydrocortisone. The particles were functionalized with a bulky azo derivative to act as a gatekeeper and stop early leakage of the drug. In vitro release models have demonstrated that most of the drug is released only in the colon, as desired. This is owing to the reductive environment in the colon (the presence of the azoreductase enzyme), where the enzymatic degradation of the azo bond resulted in controlled release. In addition, in vivo pharmacokinetic studies were conducted in a rat model of induced colitis to test the effect of the magnetic field during therapy. The findings boosted when the rats wore a magnetic belt, which extended the retention time of the particles in the desired areas [ 75 ]. Zhang et al. presented a study in which magnetic silica nanoparticles (filled with sulforaphane) were developed for the treatment of myocardial infarction [ 38 ]. In mouse models, effective accumulation was observed in the infarcted zone after the application of an external magnetic field [ 33, 75 ]. These results show the potential of using magnetic particles with magnetic field guidance [ 33 ]. Radhakrishnan et al. developed a drug delivery system (DDS) loaded with carboplatin for targeted lung cancer therapy [ 63 ]. The DDS was core-shell mesoporous silica functionalized with folic acid. Initially, the drug loading capability of the functionalized carrier was more than twice as high per surface unit compared to the non-functionalized carrier due to the anchored -NH 2 groups. The drug release was sustained but limited (up to 36%) in the case of the functionalized particle, similarly to previous cases. This is most likely owing to the stronger interactions between the amine groups and the carboplatin. The amino-functionalized particles were further functionalized with folic acid to increase cellular uptake of the particles, demonstrating the potential of folic acid-targeted therapy [ 63, 65, 76 ]. Cancer cells typically overexpress folate receptors, resulting in folate-mediated internalization that preferentially targets these cells [ 63, 76 ]. This was demonstrated in a drug-mediated cytotoxicity analysis where amino- and folate-functionalized particles were evaluated and compared. Much greater cytotoxicity was observed in cells overexpressing folate receptors [ 63 ]. Similar research was carried out by Shirani et al., where folic acid functionalized MSNs were loaded with gemcitabine as a model drug, to investigate its potential in cancer treatment, while actively targeting cancer cells [ 70 ]. Outcomes have shown that higher cellular uptake (HeLa and K562 cells) was observed in the case of the functionalized particles, compared with the non-functionalized carriers [ 70 ]. Jafarpour et al. demonstrated the importance of functionalizing the carriers to accomplish targeted therapy utilizing methotrexate as a model drug [ 76 ]. The particles were grafted with a copolymer to act as a pH-responsive gatekeeper and folic acid to actively target cancer cells [ 76 ]. Ortiz et al. similarly designed a pH-responsive DDS, loaded with the anticancer drug doxorubicin [ 11 ]. The particles were functionalized with transferrin through a pH-sensitive linker as a gatekeeper, controlling the release kinetics and preventing early leakage of the drug [ 11 ]. An interesting breast cancer therapy was published by Mal et al. using doxorubicin as API and mesoporous silica as a carrier [ 65 ]. The amine-functionalized MSNs were PEGylated and then conjugated with folic acid or hyaluronic acid. It was also published that coating the nanoparticles with polydopamine (PDA) and polyethylene glycol (PEG) brings about prolonged doxorubicin release from MSNs [ 77 ]. These conjugates enabled ligand-mediated targeted drug delivery [ 65 ]. Researchers have developed a successful DDS that targets cancer cells, thus staying away from the side effects associated with doxorubicin in conventional cancer therapy. This is important because in vitro cytotoxicity studies have shown that the free drug has higher cytotoxicity than the nanocarriers [ 65 ]. Shahbaz et al. developed a redox-responsive silica nanocarrier loaded with paclitaxel to target breast cancer cells [ 67 ]. The amine-functionalized silica core was coated with disulfide-functionalized non-porous silica shell. Then the core-shell carriers were further coated with polyethylene glycol via disulfide linkages. In vitro drug release assay verified the correlation between the redox potential of the environment and the release kinetics. This is an important finding, as it has been revealed that cancer cells possess a higher redox ability than healthy cells. This provides controlled paclitaxel release for targeted therapy. According to cell uptake and cell viability assays, this DDS is noticeably more effective than free paclitaxel, making this nanocarrier an exciting prospect [ 67 ]. These illustrations highlight the importance of surface functionalization and employing stimuli-responsive gatekeepers to attain productive targeted therapy.
- Semiconductor Grade Silica: Purity Standards, Key Specs and Typical Uses
- Because of its porous and abrasive nature, diatomaceous earth is an effective pesticide against anything with an exoskeleton. This includes just about every bug you can think of from the smallest bedbug to the largest scorpion. It is not effective on mice or other rodents, as they have the same protection to DE that we do: skin. DE works by scratching away at the waxy coating on an insect until it penetrates its shell and absorbs its fluids. This causes quick dehydration, leading to a quick death. There are several advantages and disadvantages to using DE as a pest control.
- Custom Silica: Tailoring Particle Size, Surface Treatment and Purity to Your Application
- The size of the particles greatly affects the interaction with epithelial cells, cellular absorption, and therefore their effectiveness [ 1, 10, 12 ]. Furthermore, the size also influences the leakage of the API [ 12 ]. It has been proven in vitro that epithelial permeability can be increased by decreasing the size [ 1, 12, 13, 24 ]. Zhang et al. also observed that the cellular uptake of MSNs occurred in a time-, concentration-, and size-dependent manner based on in vitro studies performed on Caco-2 cell lines (20 nm, 60 nm, 90 nm) [ 24 ]. Nevertheless, more complex findings were gained in vivo. Wang et al. compared differently sized nanoparticles in various elements (100 nm, 250 nm, 480 nm) [ 12 ]. Similarly, Lamson et al. compared MSNs with different sizes to observe the influence of the particle size on bioavailability (20-1200 nm) [ 13 ]. Larger particles (normally around 500 nm) show slower release of the API and can form a strong interaction with the cell membrane [ 12 ], but cellular uptake is limited owing to their large size [ 1, 12 ]. Smaller particles (below 100 nm) show weaker interaction with the cell membrane but exert superb cellular uptake owing to their small size [ 12 ]. On the other hand, the smaller particles can slowly diffuse through the mucin layer covering the surface of the intestinal mucosa, become trapped in it, and aggregate, further worsening the absorption [ 1, 12, 13 ]. Furthermore, the decreasing particle size leads to increased release rate, owing to the larger specific surface area and faster degradation of the particles [ 1, 12 ], which can lead to early leakage of the molecules, worsening their absorption [ 1, 12 ]. As the diameter increases, the rate of degradation and drug release kinetics decreases, so larger particles have a longer half-life [ 12 ].
- Silica Flatting Agent: Gloss Reduction Mechanism, Grades and Applications
- 50. Porras M., Adrover M.E., Pedernera M., Bucalá V., Gallo L. Novel techniques for drug loading quantification in mesoporous SBA-15 using chemometric-assisted UV and FT-IR data. J. Pharm. Biomed. Anal. 2022;216:114830. doi: 10.1016/j.jpba.2022.114830. [ DOI ] [ PubMed ] [ Google Scholar ]
Is Silica in Cosmetics Safe? Ingredient Safety and Regulatory Status
What is silica (SiO₂)?
silica particle size 73. Manzano M., Vallet-Regí M. Mesoporous silica nanoparticles in nanomedicine applications. J. Mater. Sci. Mater. Med. 2018;29:65. doi: 10.1007/s10856-018-6069-x. [ DOI ] [ PubMed ] [ Google Scholar ]
What is the difference between fumed silica and precipitated silica?
silica for powder coatings
What drives silica raw material prices?
silica supplier
Cite this article: Silica Raw Materials News. "Fused Silica Powder Supplier: Purity, Particle Size Options and Selection Tips
." Published 2026-11-20 00:28:27.
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.